Pharmaceutical preparations, namely, pharmaceutical preparations for use in the treatment of gastrointestinal diseases; laxatives and purgative agents; pharmaceutical preparations for use in the treatment of cardiovascular diseases; pharmaceutical preparations for use in the treatment pharmaceutical preparations for use in the treatment of cancer; pharmaceutical preparations for use in the treatment of neurological diseases; pharmaceutical preparations for use in the treatment of urological diseases;pharmaceutical preparations for use in the treatment of hormonal disorders; pharmaceutical preparations comprising peptides for hormonal treatment and tumor treatment; pharmaceutical preparations for use in the treatment of endocrine disorders; pharmaceutical preparations for use in the treatment of acromegalia and carcinoid tumors; pharmaceutical preparations for use in the treatment of blood diseases; pharmaceutical preparations for use in the treatment of gastrointestinal bleeding disorders; pharmaceutical preparations for use in the treatment of muscle disorders; pharmaceutical preparations for use in the treatment of age-related disorders; pharmaceutical preparations for use in the treatment of diabetes, diabetes-related disorders; pharmaceutical preparations for use in the treatment of respiratory disorders; pharmaceutical preparations for use in the treatment of ophthalmological disorders; pharmaceutical preparations against cough; pharmaceutical preparations for use in the treatment of vertigo, nausea, vomiting and migraine; pharmaceutical preparations for use in the treatment of disorders and diseases of the reproductive system; pharmaceutical preparations for use in the treatment of glabellar lines, facial wrinkles, asymetries and defects and conditions of the human skin; and Veterinary preparations, namely, veterinary preparations for use in the treatment of gastrointestinal diseases; veterinary laxatives and purgative agent; veterinary preparations for use in the treatment of cardiovascular diseases; veterinary preparations for use in the treatment of circulatory disorders; veterinary preparations for use in the treatment of neurological diseases; veterinary preparations for use in the treatment of urological diseases; veterinary preparations for use in the treatment of blood diseases; and veterinary preparations for use in the treatment of muscle disorders

Class [042]
Computer & Software Services & Scientific Services

Research and development services for chemical and pharmaceutical products

Mark Details

Serial Number

No 78187797

Mark Type

No Service Mark

Attorney Docket Number

No 425,036

44D Filed

44D Current

44E filed

44E Current

66A Filed

66A Current

Current Basis

No Basis

Legal History

Status Date	Action Taken
27^th Mar 2015	CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
01^st Apr 2009	AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
15^th May 2007	REGISTERED - SEC. 7 REQUEST ABANDONED
28^th Sep 2006	POST REGISTRATION ACTION MAILED - SEC. 7
28^th Nov 2005	PAPER RECEIVED
28^th Nov 2005	RESPONSE RECEIVED TO POST REG. ACTION
30^th Jun 2005	POST REGISTRATION ACTION MAILED - SEC. 7
20^th May 2005	TEAS CHANGE OF CORRESPONDENCE RECEIVED
27^th Apr 2005	PAPER RECEIVED
04^th Apr 2005	PAPER RECEIVED

DOPASTATIN

Classification Information

Class [001]Chemical Products

Class [005]Pharmaceutical Products

Class [042]Computer & Software Services & Scientific Services